IDYA

Bullish

LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $62

LifeSci Capital has reiterated its Buy rating on IDEAYA Biosciences (IDYA.US), maintaining a target price of $62. This indicates a positive outlook on...

Moomoo Yesterday 0

Bullish

Why Is IDYA Stock Surging Over 20% Overnight?

Ideaya Biosciences (IDYA) stock surged over 20% overnight ahead of topline data from its late-stage Darovasertib combination study for metastatic uvea...

Stocktwits 2 weeks ago 0